Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein.

Science
G J Gleich, G L Jacob

Abstract

The quantities of immunoglobulin E (IgE) antibodies to grass or ragweed allergens were measured by an immunoabsorption in the serums of patients sensitive to one of these allergens. IgE antibodies to grass or ragweed allergens accounted for means of 30 and 29 percent of the total IgE protein. After the ragweed pollination season, the levels of serum IgE antibodies to ragweed allergens rose dramatically and in postpollination serums they accounted for 39 percent of the total IgE protein with a range from 13 to 50 percent.

References

Jan 1, 1975·The Journal of Allergy and Clinical Immunology·L L HendersonG J Gleich
Feb 1, 1975·Pediatric Clinics of North America·J W Yunginger, G J Gleich
May 1, 1975·The Journal of Allergy and Clinical Immunology·G J Gleich, R T Jones
Aug 1, 1972·The Journal of Allergy and Clinical Immunology·J W Yunginger, G J Gleich
Feb 1, 1973·The Journal of Clinical Investigation·L M LichtensteinB M Hill
Jan 1, 1968·Advances in Immunology·A G OslerD A Levy
Mar 1, 1974·The Journal of Allergy and Clinical Immunology·G J GleichH Baer
Mar 1, 1973·The Journal of Allergy and Clinical Immunology·J W Yunginger, G J Gleich
Jan 1, 1969·Immunochemistry·G J Gleich, R R Stankievic
Nov 30, 1935·The Journal of Experimental Medicine·R A CookeA Stull
Jan 1, 1939·The Journal of Experimental Medicine·A Tiselius, E A Kabat

❮ Previous
Next ❯

Citations

Jan 1, 1984·The Journal of Allergy and Clinical Immunology·P S CreticosN F Adkinson
May 4, 2005·The Journal of Allergy and Clinical Immunology·Elizabeth A ErwinThomas A E Platts-Mills
Jun 3, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·B K ThakurD Volkman
May 15, 2001·Allergy·J S Wild, S Sur
Feb 19, 1977·British Medical Journal
Jan 28, 2012·American Journal of Respiratory and Critical Care Medicine·Scott P ComminsThomas A E Platts-Mills
Nov 10, 2013·PloS One·Anna N BerlinaBoris B Dzantiev
Nov 11, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M E WeissN F Adkinson
Mar 8, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Thomas A E Platts-MillsJudith A Woodfolk
Jan 21, 2009·The Journal of Allergy and Clinical Immunology·Elizabeth A ErwinThomas A E Platts-Mills
Sep 11, 2007·The Journal of Allergy and Clinical Immunology·Helena PerssonMats Ohlin
Sep 5, 2007·The Journal of Allergy and Clinical Immunology·Thomas A E Platts-MillsDiane R Gold
Feb 13, 2007·The Journal of Allergy and Clinical Immunology·Thomas A E Platts-Mills
Feb 13, 2007·The Journal of Allergy and Clinical Immunology·Elizabeth A ErwinThomas A E Platts-Mills
Nov 22, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·N WopfnerM Chapman
Sep 1, 1979·Clinical Immunology and Immunopathology·A K BamzaiS P Gotoff
May 1, 1982·Allergy·E G ShephardJ R Joubert
Sep 1, 1977·The Journal of Allergy and Clinical Immunology·G J GleichL L Henderson
Apr 1, 1988·The Journal of Allergy and Clinical Immunology·P A Greenberger, R Patterson
May 10, 2015·The Journal of Allergy and Clinical Immunology·Yvonne ReschSusanne Vrtala
Sep 1, 1979·International Journal of Dermatology·N A Soter, S I Wasserman
Oct 1, 1985·Annals of Tropical Medicine and Parasitology·C G TeoL C Ho
Apr 12, 2001·Allergy·L Yman
Jan 1, 1989·Clinical Reviews in Allergy·G M Halpern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.